|
Volumn 360, Issue , 2007, Pages 253-268
|
The HUVEC/Matrigel assay: an in vivo assay of human angiogenesis suitable for drug validation.
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOGENIC FACTOR;
CD31 ANTIGEN;
COLLAGEN;
DNA BINDING PROTEIN;
ENDOSTATIN;
LAMININ;
MATRIGEL;
PROTEOGLYCAN;
RAG2 PROTEIN, MOUSE;
ANGIOGENESIS;
ANIMAL;
ARTICLE;
CELL CULTURE;
CYTOLOGY;
DRUG COMBINATION;
DRUG EFFECT;
DRUG SCREENING;
GENETICS;
HUMAN;
IMMUNE DEFICIENCY;
METHODOLOGY;
MOUSE;
MOUSE MUTANT;
SUBCUTANEOUS DRUG ADMINISTRATION;
UMBILICAL VEIN;
VASCULAR ENDOTHELIUM;
ANGIOGENESIS INDUCING AGENTS;
ANIMALS;
ANTIGENS, CD31;
CELLS, CULTURED;
COLLAGEN;
DNA-BINDING PROTEINS;
DRUG COMBINATIONS;
DRUG EVALUATION, PRECLINICAL;
ENDOSTATINS;
ENDOTHELIUM, VASCULAR;
HUMANS;
IMMUNOLOGIC DEFICIENCY SYNDROMES;
INJECTIONS, SUBCUTANEOUS;
LAMININ;
MICE;
MICE, KNOCKOUT;
NEOVASCULARIZATION, PHYSIOLOGIC;
PROTEOGLYCANS;
UMBILICAL VEINS;
|
EID: 38549104296
PISSN: 10643745
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (21)
|
References (0)
|